Literature DB >> 2547238

In vitro sensitivity of human herpesvirus-6 to antiviral drugs.

H Agut1, H Collandre, J T Aubin, D Guétard, V Favier, D Ingrand, L Montagnier, J M Huraux.   

Abstract

We studied the sensitivity of human herpesvirus-6 (HHV-6) to 4 antiviral drugs known to be effective in the treatment of infections with other human herpesviruses and human immunodeficiency virus. HHV-6 was grown in peripheral blood lymphocytes, and virus multiplication was quantified by evaluation of the cytopathic effect by molecular hybridization and indirect immunofluorescence assay. The 50% and 90% inhibitory concentrations (IC50 and IC90) were determined for each drug. The results obtained by the 3 different quantification techniques were found to correlate, and enabled us to conclude that HHV-6 replication was readily inhibited by foscarnet or ganciclovir. In contrast, inhibition of HHV-6 replication was observed only at high concentrations of acyclovir, and was not detected at the tested concentrations of zidovudine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547238     DOI: 10.1016/s0923-2516(89)80099-8

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  9 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Herpesvirus infections in organ transplant recipients.

Authors:  Frank J Jenkins; David T Rowe; Charles R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

3.  Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents.

Authors:  Muriel Macé; Chaysavanh Manichanh; Pascale Bonnafous; Stéphanie Précigout; David Boutolleau; Agnès Gautheret-Dejean; Henri Agut
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 4.  Human herpesvirus-6 infections.

Authors:  C A Jones; D Isaacs
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

5.  Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology.

Authors:  Hiroyuki Hiramatsu; Ryota Suzuki; Shigeki Yamada; Masaru Ihira; Yuji Isegawa; Yoshiki Kawamura; Erina Matsuoka; Hiroki Miura; Tetsushi Yoshikawa
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

Review 6.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.

Authors:  Jan Lycke; Clas Malmeström; Lars Ståhle
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds.

Authors:  A Akesson-Johansson; J Harmenberg; B Wahren; A Linde
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 9.  Meningoencephalitis caused by human herpesvirus-6 in an immunocompetent adult patient: case report and review of the literature.

Authors:  D Torre; F Speranza; R Martegani; P Ferrante; E Omodeo-Zorini; R Mancuso; G P Fiori
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 7.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.